Work Life

UChicago Medicine Center for Care and Discovery - Hyde Park is one of the largest buildings on our Hyde Park medical campus. The building opened in 2013. It was created with a flexible design that makes it easy to update the space as we continually incorporate new technology and expand our treatment options. Spacious and easy to navigate, the CCD fosters more collaboration among clinicians and staff while making it easy to actively engage our patients and families in medical care. 

Learn more: Center for Care & Discovery

UChicago Medicine Duchossois Center for Advanced Medicine, also known as DCAM, is our flagship outpatient facility.

Located in Chicago's historic Hyde Park neighborhood, this six-story building puts comprehensive diagnostic care and world-class treatment under one roof. Home to dozens of primary and specialty clinics as well as a pharmacy, the building includes more than 300 exam rooms, nearly 100 procedure rooms, surgery suites and imaging equipment including PET/CT and MRI scanners. It also has facilities for nuclear medicine along with linear accelerators and simulators for radiation therapy.

DCAM brings the knowledge and resources of UChicago Medicine to the outpatient setting, including clinical trials in virtually every medical area and more research funded by the National Institutes of Health than anyplace else in Illinois.

Learn more: Duchossois Center for Advanced Medicine

UChicago Medicine Mitchell Hospital - Hyde Park is a six-story hospital at the heart of our historic Hyde Park campus.

An integral part of our academic medical center, the Bernard A. Mitchell Hospital is home to a variety of specialty care, including our post-natal mother-baby unit, advanced imaging services, physical therapy services and in-patient units. Other amenities include wireless internet, a chapel, an on-site restaurant and a gift shop.

Learn more: Mitchell Hospital

At the University of Chicago Medicine, we provide the most contemporary, innovative care for the full range of common and complex blood flow problems affecting the brain and spinal cord. Our collaborative, approach draws on the talents and internationally recognized expertise of leading clinicians in neurology, neurosurgery and neurointerventional surgery. Our team includes pioneering experts in these specialties, offering a depth and breadth of experience that enables us to help people with the most challenging neurovascular problems. Our team provides thorough and compassionate care at every level of illness and for patients at every age.

Learn more: Stroke Center

The University of Chicago Medicine is designated as a Level 1 Adult Trauma Center, meaning the hospital is prepared to handle the most seriously injured trauma patients 24 hours a day, seven days a week. Together with its Level 1 Pediatric Trauma Center at Comer Children's Hospital and its Burn and Complex Wound Center, UChicago Medicine is able to provide the community a comprehensive system of care to treat the full range of trauma injuries in patients of all ages.

UChicago Medicine began providing Level 1 adult trauma care on May 1, 2018, nearly 30 years after discontinuing the program. The academic medical center has offered Level 1 pediatric trauma care since 1990.

The institution is home to the South Side of Chicago's only Level 1 Pediatric Trauma Center and the University of Chicago Medicine Aeromedical Network (UCAN), which provides helicopter transportation from the scene of an emergency to our Hyde Park campus or between hospitals within a 200-mile radius.

Through our Urban Health Initiative, we are partnering with and supporting community organizations to provide trauma patients and their families with wraparound services, violence-recovery efforts and other services that ensure they can recover from traumatic injuries.

Our Services

We provide trauma surgery, acute care surgery and critical care surgery to treat injuries involving:

  • Burns
  • Blunt trauma, which can occur from falls or pedestrian-motor vehicle crashes
  • Penetrating trauma, typically seen in gunshot or stab wounds

Click here to learn more:

We have a new and expanded emergency department (ED) that also offers adult trauma care. The new ED features an efficient layout and design, which has cut waiting, admitting and discharge times. It is connected to the Center for Care and Discovery, allowing for effi cient access to lifesaving resources such as operating rooms. For example, the longest travel time to operating rooms in the CCD has been reduced by 50 percent – from 15 minutes to
7 minutes. The new ED opened in December 2017, followed by the trauma center in May 2018.

The new ED has 41 treatment stations, 4 trauma resuscitation bays, 7 rapid assessment units, 4 psychiatric rooms, 1 bariatric room, dedicated imaging facilities, rapid assessment unit for patients who need minor medical care, and on-site biocontainment unit to deal with infectious diseases and biological agents. Additionally, patients experience more privacy, with separate rooms instead of curtained cubicles, and they have a dedicated patient entrance as well a separate entrance for EMS/paramedics. Patients and emergency responders shared an entrance to the old adult ED.

In addition to the new ED, Mitchell Hospital will be turned into a facility dedicated to the care of patients with cancer. The initial conversion of Mitchell will be phased over time, but began in late 2017.

Learn more: Emergency Department

Comer Children's is advancing the forefront of kids' health. Our pediatric specialists are committed to offering every child the latest treatments and clinical breakthroughs. Because we believe kids of all ages should be able to grow up to be healthy, happy and strong.

Learn more: Comer Children's Hospital

PGY2 residents will gain exposure to a variety of subspecialties while at North Shore. The rotation takes place at primarily the Glenbrook campus, but also at the Evanston Campus for a duration of 2 months. The resident will be involved in multidisciplinary outpatient neurology specialty clinics where they will be assigned to a particular specialty clinic on a daily basis divided into half day blocks. During each half day block, a patient will be scheduled specifically for the resident and will be staffed by the appropriate staff for that subspecialty. The resident will be responsible for evaluating the patient and developing diagnostic and therapeutic management plans for these patients in collaboration with the attending.

Learn more: North Shore University Health System - Glenbrook

PGY3 residents will work on refining their diagnostic and management skills while on the general neurology consultation service rotation at North Shore University HealthSystem. The Consult Service covers all of the adult inpatient units including Medicine, Surgery, medical/surgical ICUs, OB-GYN, and Psychiatry.  The Neurology resident will be the first to evaluate patients as requested by the various services.

Learn more: North Shore University Health System - Evanston

PGY4s will spend their time at North Shore focusing on subspeciality interests. Residents can work with up to 40 additional neurologists in 11 subspecialty areas and can choose from numerous electives among the various North Shore locations. North Shore has an expanded patient experience with a different patient population. Elective choices can include:

  • Cognitive
  • EMU
  • Epilepsy Clinic
  • General Neurology
  • Movement Disorders
  • NeuroImmunology
  • Neuromuscular
  • NeuroOncology
  • NeuroOphthalmology
  • Neurophysiology
  • Sleep
  • Vascular/Stroke

North Shore locations:

Honoring Barry G.W. Arnason MD, the annual Barry G.W. Arnason Resident Research Symposium gives residents an opportunity to showcase their research in the form of a platform presentation, or poster. Presentations are critiqued by a guest lecturer (usually a residency alum) who presents the winners at the Graduation Banquet. One presentation from each PGY class is chosen as the winner and awarded a digital copy of Adams and Victor's Principles of Neurology.

  • Evidence for Amyloid Scanning (IDEAS) Study.  Assessing the impact of amyloid positron emission tomography (PET) imaging on outcomes in patients with mild cognitive impairment or dementia of uncertain origin
  • The “Graduate Study” - Monoclonal Antibody Therapy for Alzheimer’s Disease” is in progress
  • Molecular mechanisms of neurodegeneration in Alzheimer’s Disease and Prion diseases
  • The role of sleep in memory consolidation in early stage Alzheimer’s disease
  • Detecting tau protein from nasally expired air in Alzheimer’s and other diseases
  • Trial site for SLATE – Stereotactic Laser Ablation for Temporal Lobe Epilepsy
  • Combining intracranial electrophysiological recording and imaging to develop biomarkers for hippocampal epilepsy
  • Development and testing of a cortical visual prosthesis (a multi-institutional collaboration led by V. Leo Towle PhD)
  • Understanding the deep brain circuits involved in attention and memory (collaboration with the Departments of Neurobiology and Psychology)
  • Investigating genetic susceptibilities in primary generalized epilepsy (collaboration with the Department of Neurobiology)
  • Using neurophysiological recordings and mathematical analysis to better understand how central motor systems coordinate limb movement
  • Understanding the role of seizures in the pathophysiology of neurocysticercosis
  • Understanding and preventing SUDEP
  • Ataxias: spinocerebellar, Friedreich’s, olivopontocerebellar, and many more
  • Neurodegenerative diseases
  • Ion channel disorders
  • Movement disorders: Parkinson’s disease, PSP, MSA, CBGD, LBD, tremor, dystonia, Huntington’s disease, hemifacial spasm, and many more
  • A novel role for a bicistronic calcium channel gene in neurodevelopment and neurodegeneration, overlapping cistrons in a family of ion channel genes in spinocerebellar ataxias (funded by NINDS)
  • Deep brain stimulation in gait and swallowing function, and biomarkers in Parkinson disease  (funded by Michael J Fox Foundation for PD)
  • Antibody infusion in the treatment of Progressive Supranuclear Palsy (PSP; BMS and Abbvie sponsored, multi-sites)
  • African American PD: Clinical features and genetic profiles (funded by Parkinson’s Foundation)
  • Multiple system atrophy (MSA) biomarker (funded by NIH/NINDS and private donation, multi-sites in brain imaging study)
  • Caffeine as a biomarker in Parkinson Disease (funded by Michael J Fox Foundation, multi-sites)
  • Dystonia coalition (funded by NIH/NINDS, multi-sites) and the Office of Rare Diseases Research (ORDR)
  • Intranasally administered IGF-1 inhibits spreading depression in vivo
  • NIH workshop report on the trans-agency blood-brain interface workshop 2016: exploring key challenges and opportunities associated with the blood, brain and their interface.
  • Environmental Enrichment Stimulates Immune Cell Secretion of Exosomes that Promote CNS Myelination and May Regulate Inflammation
  • BOOST III Trial: phase III RCT to evaluate outcome with PbtO2 directed therapy vs. ICP directed therapy in severe TBI
  • MISTIE III: Minimally Invasive Surgery Plus rt-PA for intracerebral Hemorrhage Evacuation is a phase III RCT evaluating outcome in patients with ICH treated with catheter directed lytic therapy
  • CLEAR III: Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
  • Penetrating traumatic brain injury
  • Prognosis after cardiac arrest
  • Stroke code activation demographics
  • Neurologic complications of ventricular assist devices
  • Longitudinal evaluation of brain and spinal cord atrophy in MS
  • Longitudinal evaluation of gray and white matter injury using nonconventional MRI techniques
  • Advanced MRI measures of repair in relapsing/remitting MS patients and Alemtuzemab-treated patients
  • Abnormal IFN-b-1b signaling, cellular and molecular mechanisms of IFN, and IFN resistance in MS
  • Fc-IgG tetramer to modify immunity in experimental autoimmune enchephalitis and MS
  • Targeting the integrated stress response to protect oligodendrocyte lineage cells, DTA oligodendrocyte ablation model in the study of inflammatory demyelination, and investigating the role that ZFP191 phosphorylation state plays in regulating oligodendrocyte maturation, and new PET imaging technology
  • A Double-Blind, Randomized, Multicenter, Placebo Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fingolimod 0.5 mg Administered Orally Once Daily Versus Placebo in Patients with Chronic Inflammatory
  • Demyelinating Polyradiculoneuropathy
  • Assessment of intermuscular coherence as a biomarker for ALS and commercialization of a diagnostic test for ALS
  • SOD1 designed ankyrin repeat protiens (DARPins), a genetically engineered antibody mimetic protein, as a treatment for ALS
  • Unconventional translation of the expanded repeat of a gene, C9ORF72
  • Targeting the integrated stress response in ALS
  • Studies of Theiler’s virus-induced immune mediated demyelinating disease, a model of MS
  • Clinical Trials
    • Carbonic anhydrase inhibition for newly diagnosed malignant glioma: open
    • Brachyury vaccine for chordoma: going to IRB next month
    • High avidity NK cells for meningioma: concept stage
    • PP2A inhibition with radiation for brain metastases: concept stage
  • Laboratory Research
    • Intratumoral hypoxia and cell signaling
  • ACTIsSIMA: Double-Blind, controlled phase IIB study of Modified Stem Cells (SB623) in the treatment of motor deficits in ischemic stroke
  • CREST-II: Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial
  • RESPECT-ESUS: A randomized, double-blind evaluation in secondary stroke prevention comparing the efficacy and safety of the thrombin inhibitor dabigatran etexilate vs acetylsalicylic acid in patients with embolic stroke of underdetermined source (ESUS)
  • Oldest and largest clinical ethics fellowship in the world
  • Directed by Mark Siegler MD, who is the founder of the field
  • Can be done during the PGY4 year
  • The neurology program leadership is supportive in adjusting the schedule to fulfill duties of both neurology PGY4 year and the ethics fellowship


  • Some numbers:
    • 450 fellows trained
    • 330 physician fellows
    •   32 former fellows who have directed ethics programs
    •   25 former fellows who have held endowed chairs
    • 210 books written by former fellows and faculty

Click here to learn more:

Medical Education, Research, Innovation, Teaching, and Scholarship

  • Two year residency track focusing on a curriculum to develop educational leaders and scholars through workshops, mentored projects, lecture series, and national conferences


In January 2018, the IGNITE (Improving GME-Nursing Interprofessional Team Experiences) program launched a Neuro team

  • IGNITE aims to pair residents, nurses and care managers to form a unit-based performance improvement team
  • We identified common areas that needed improvement in regards to patient care
  • We then focused on improving hand-off communication, specifically focusing on “B-BRAINS”
  • Neuro IGNITE aims to reduce unnecessary overnight pages and ensure patient care team is looped in on patient plan of care through establishing a quick afternoon huddle between the senior resident and day nurses

Awardees are chosen for this award by the current third year class of the Pritzker School of Medicine on the basis of demonstrated professionalism and stature as a role model for medical students.